Posts
uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart
Source: PR Newswire · uSMART Securities (Singapore) Pte Ltd · View original releaseSINGAPORE, Oct. 26, 2026 /PRNewswire/ -- uSMART Securities (Singapore) Pte. Ltd. ("uSMART") has...
From Vietnam National Brand to Regional Giant: SUNHOUSE Secures Second Consecutive APEA Corporate Excellence Award
Source: PR Newswire · SUNHOUSE Group · View original releaseHANOI, Vietnam, Oct. 26, 2026 /PRNewswire/ -- At the Asia Pacific Enterprise Awards (APEA) 2026, SUNHOUSE...
Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026
Source: PR Newswire · Antengene Corporation Limited · View original release SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK:...
26th Shanghai Fair Returns to Kuala Lumpur to Strengthen Trade and Cultural Ties
Source: PR Newswire · RCG International Convention & Exhibition Co. Limited · View original releaseKUALA LUMPUR, Malaysia, Oct. 26, 2026 /PRNewswire/ -- The 26th Shanghai...
2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein
Source: PR Newswire · Innovent Biologics · View original release The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC,...
Celebrate the Magic of Christmas and New Year at Phuket Marriott Resort & Spa, Merlin Beach
A tropical festive escape filled with family activities, exceptional dining and memorable celebrations by the Andaman Sea Phuket Marriott Resort & Spa, Merlin Beach invites...
World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang
Source: PR Newswire · China Daily · View original releaseWENZHOU, China, Oct. 25, 2026 /PRNewswire/ -- A news report from China Daily: On October 24,...
Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
Source: PR Newswire · Kelun-Biotech · View original release Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months),...
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
Source: PR Newswire · Kelun-Biotech · View original release PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was...